Asston Pharmaceu — 360° view

Asston Pharmaceu, a company in the Pharmaceuticals industry, reported revenue of ₹15 crore and net profit of ₹3.27 crore for the September 2026 quarter.

Asston Pharmaceu (BSE: APL) closed at ₹162.20 on 20 Nov 2026, up 88.6% over the past year. Its market capitalisation is ₹177 crore and it trades at 47.2 times earnings.

Share price
₹162.20 (20 Nov 2026)
Market cap
₹177 Cr (20 Nov 2026)
P/E
47.24 (20 Nov 2026)
Revenue
₹15 Cr (September 2026 quarter)
Net profit
₹3 Cr (September 2026 quarter)
ROCE
17.0% (FY26)
ROE
15.7% (FY26)
Book value
₹64.0 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹165.70 / ₹60.00 (20 Nov 2026)
1-year return
88.6% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: APL

Incorporated in 2019, Asston Pharmaceuticals Ltd is in the business of manufacturing pharmaceutical products.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.